Great West Life Assurance Co. Can continued to hold its position in Vitamin Shoppe Inc. (NYSE:VSI) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,539 shares of the company’s stock at the end of the second quarter. Great West Life Assurance Co. Can’s holdings in Vitamin Shoppe were worth $109,000 as of its most recent SEC filing.
Several other institutional investors have also recently bought and sold shares of the company. Envestnet Asset Management Inc. boosted its position in Vitamin Shoppe by 10.0% in the first quarter. Envestnet Asset Management Inc. now owns 4,068 shares of the company’s stock worth $126,000 after buying an additional 371 shares during the last quarter. BlackRock Group LTD boosted its stake in shares of Vitamin Shoppe by 7.3% in the first quarter. BlackRock Group LTD now owns 37,164 shares of the company’s stock valued at $1,150,000 after buying an additional 2,521 shares in the last quarter. BNP Paribas Arbitrage SA boosted its stake in shares of Vitamin Shoppe by 95.2% in the second quarter. BNP Paribas Arbitrage SA now owns 8,461 shares of the company’s stock valued at $259,000 after buying an additional 4,126 shares in the last quarter. GW&K Investment Management LLC boosted its stake in shares of Vitamin Shoppe by 12.4% in the second quarter. GW&K Investment Management LLC now owns 42,609 shares of the company’s stock valued at $1,303,000 after buying an additional 4,694 shares in the last quarter. Finally, Daiwa Securities Group Inc. boosted its stake in shares of Vitamin Shoppe by 932.1% in the second quarter. Daiwa Securities Group Inc. now owns 7,400 shares of the company’s stock valued at $226,000 after buying an additional 6,683 shares in the last quarter.
Shares of Vitamin Shoppe Inc. (NYSE:VSI) traded down 1.51% on Thursday, hitting $26.12. The stock had a trading volume of 147,652 shares. The company has a market cap of $616.01 million, a P/E ratio of 15.30 and a beta of 0.67. Vitamin Shoppe Inc. has a 52-week low of $26.02 and a 52-week high of $34.41. The company has a 50-day moving average of $27.07 and a 200-day moving average of $29.21.
Vitamin Shoppe (NYSE:VSI) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $0.55 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.59 by $0.04. The company earned $332.70 million during the quarter, compared to analysts’ expectations of $331.58 million. Vitamin Shoppe had a return on equity of 11.53% and a net margin of 3.56%. The company’s revenue was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.57 EPS. On average, equities analysts anticipate that Vitamin Shoppe Inc. will post $2.18 EPS for the current fiscal year.
Several equities research analysts recently weighed in on VSI shares. Zacks Investment Research cut Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Wednesday, August 3rd. Wedbush restated an “outperform” rating and set a $39.00 target price on shares of Vitamin Shoppe in a report on Wednesday, August 3rd. Jefferies Group restated a “hold” rating on shares of Vitamin Shoppe in a report on Thursday, August 4th. Finally, Barclays PLC started coverage on Vitamin Shoppe in a report on Thursday, September 22nd. They set an “equal weight” rating and a $29.00 target price for the company. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $32.27.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.
Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe Inc. (NYSE:VSI).
Receive News & Ratings for Vitamin Shoppe Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc. and related companies with MarketBeat.com's FREE daily email newsletter.